Conformity of cleia and clia HBsAg quantitative assay with qPCR gold standard in hepatitis B patients

Victoria Indah Mayasari; Aryati Aryati

doi:10.53730/ijhs.v6nS1.5275

Authors

Victoria Indah Mayasari Clinical Pathology Specialization Program, Department of Clinical Pathology, Faculty of Medicine Airlangga University, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Aryati
aryati@fk.unair.ac.id
Department of Clinical Pathology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia

Keywords:

Quantitative HBsAg, CLEIA, CLIA, qPCR

Abstract

Quantitative HBsAg assay is an alternative marker of potential viremia and monitoring response to antiviral treatment. Various methods have been developed to assess HBsAg quantification. This cross-sectional observational research aims to understand the performance of quantitative HBsAg assay with CLEIA (Chemiluminescence Enzyme Immunoassay) and CLIA (Chemiluminescence Immunoassay) methods and their compliance with qPCR. Serum samples were obtained from 69 Hepatitis B patients at the Outpatient Clinic. Quantitative HBsAg assay was performed with Sysmex HISCL-5000 and Mindray CL-900i, HBV DNA by using GeneXpert^® HBV Viral Load. The results showed that the HBsAg value of the CLEIA method ranged from 9.77 to >2,500 IU/mL, while the CLIA method ranged from 19.97 to >50,000 IU/mL. Analysis of the CLEIA and CLIA methods showed agreement ((LoA: -5014.01 – 1815.33) with the relationship between the two methods showed a positive correlation (p <0.05). There is a positive correlation between HBsAg results using CLEIA method and HBV DNA (p <0.05) and also between the HBsAg CLIA method and HBV DNA (p <0.05).

Downloads

Download data is not yet available.

References

Agarwal K, Berg T, Buti M, Janssen HLA, Lampertico P, Papatheodoridis G, Tacke F and Zoulim F (2017) EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 67: 370–398.

Cornberg M, Wong VWS, Locarnini S, Brunetto M, Janssen HLA and Chan HLY (2017) The role of quantitative hepatitis B surface antigen revisited. J Hepatol. 66: 398–411.

Deguchi M, Kagita M, Yoshioka N, Tsukamoto H, Takao M, Tahara K, Maeda I, Hidaka Y, Yamauchi S, Kaneko A, Miyakoshi H and Isomura M (2018) Evaluation of the highly sensitive chemiluminescent enzyme immunoassay “Lumipulse HBsAg-HQ” for hepatitis B virus screening. J Clin Lab Anal. 32: 1–10.

Fibriani A, Wisaksana R, Alisjahbana B, Indrati A, Schutten M, van Crevel R, van der Ven A and Boucher CA (2014) Hepatitis B virus prevalence, risk factors and genotype distribution in HIV infected patients from West Java, Indonesia. J Clin Virol. 59: 235-241.

Gunardi H, Zaimi LF, Soedjatmiko, Turyadi, Harahap AR and Muljono DH (2014) Current prevalence of hepatitis B infection among parturient women in Jakarta, Indonesia. Acta Med Indones. 46: 3-9.

Humairah I, Lukitasari L, Handajani R, Amin M, Wungu CDK, Rianto E and Ansori ANM (2021) Prevalence and genotype distribution of hepatitis C virus among intravenous drug users (IDUs) in Surabaya, Indonesia. Res J Pharm Technol. 14: 1999.

Ie SI, Turyadi, Sidarta E, Sadhewa A, Purnomo GA, Soedarmono YS, Pattiiha MZ, Thedja MD, Harahap AR and Muljono DH (2015) High Prevalence of Hepatitis B Virus Infection in Young Adults in Ternate, Eastern Indonesia. Am J Trop Med Hyg. 93: 1349-1355.

Mak LY, Seto WK, Fung J and Yuen MF (2020) Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B. Hepatol Int. 14: 35–46.

Muljono D, Wijayadi T and Sjahril R (2018) Hepatitis B Virus Infection among Health Care Workers in Indonesia. Euroasian J Hepatogastroenterol. 8: 88-92.

Muljono HD (2017) Epidemiology of Hepatitis B and C in Republic of Indonesia. Euroasian J Hepatogastroenterol. 7(1): 55-59.

Mulyanto, Depamede SN, Surayah K, Tsuda F, Ichiyama K, Takahashi M and Okamoto H (2009) A nationwide molecular epidemiological study on hepatitis B virus in Indonesia: identification of two novel subgenotypes, B8 and C7. Arch Virol. 154: 1047-59.

Nelwan EJ, Van Crevel R, Alisjahbana B, Indrati AK, Dwiyana RF, Nuralam N, Pohan HT, Jaya I, Meheus A and Van Der Ven A (2010) Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Trop Med Int Health. 15: 1491.

Nguyen MH, Wong G, Gane E, Kao JH and Dusheiko G (2020) Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev. 33: e00046-19.

Nurtjahyani SD, Probojati RT, Ansori ANM, Amin M and Handajani R (2021) Haplotype network analysis and phylogenetic tree construction of hepatitis C virus (HCV) isolated from Tuban, Indonesia. Res J Pharm Technol. 14: 4231-4235.

Purwono PB, Juniastuti, Amin M, Bramanthi R, Nursidah, Resi EM, Wahyuni RM, Yano Y, Soetjipto, Hotta H, Hayashi Y, Utsumi T and Lusida MI (2016) Hepatitis B Virus Infection in Indonesia 15 Years After Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant. Am J Trop Med Hyg. 95: 674-679.

Rinonce HT, Yano Y, Utsumi T, Heriyanto DS, Anggorowati N, Widasari DI, Lusida MI, Soetjipto, Prasanto H, Hotta H and Hayashi Y (2013) Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission. J Med Virol. 85: 1348-1361.

Song JE and Kim DY (2016) Diagnosis of hepatitis B. Ann Transl Med. 4(18): 338.

Tang LSY, Covert E, Wilson E and Kottilil S (2019) Chronic Hepatitis B infection a review. JAMA - J Am Med Assoc. 319: 1802–1813.

Utsumi T, Yano Y, Lusida MI, Amin M, Soetjipto, Hotta H and Hayashi Y (2010) Serologic and molecular characteristics of hepatitis B virus among school children in East Java, Indonesia. Am J Trop Med Hyg. 83(1): 189-193.

Utsumi T, Yano Y, Lusida MI, Nasronudin, Amin M, Juniastuti, Soetjipto, Hotta H and Hayashi Y (2013) Detection of highly prevalent hepatitis B virus co-infection with HIV in Indonesia. Hepatol Res. 43: 1032-9.

Yano Y, Utsumi T, Lusida MI and Hayashi Y (2015) Hepatitis B virus infection in Indonesia. World J Gastroenterol. 21: 10714-10720.